Moderna and Merck Present Phase 3 Melanoma Data on Personalized Cancer Vaccine
Moderna and Merck present Phase 3 melanoma findings for their personalized mRNA cancer vaccine; endpoints, effect sizes and filing plans await full disclosure.
Topic
Mrna Vaccine
Topic
Mrna Vaccine
An mRNA Cancer Vaccine Gave One Melanoma Patient a Path Forward
A melanoma diagnosis led one patient to an investigational mRNA cancer vaccine, STAT reports — a story that signals where skin-ca…
Keytruda Plus mRNA Vaccine Shows Promise in Skin Cancer Trial
Merck's Keytruda paired with a personalized mRNA vaccine produced 'promising' results in a skin cancer trial, the company reporte…
Elsner Highlights Personalized mRNA Therapies for High-Risk Melanoma
Dr. Caroline Elsner discusses personalized mRNA-based therapies for high-risk melanoma in an Oncodaily feature, as the adjuvant v…
WVU Medicine Flags mRNA Melanoma Vaccine as News of Note
WVU Medicine spotlights an mRNA melanoma vaccine in its news channel. No new data, but the counseling conversation for dermatolog…
mRNA Vaccine Shows Promise Against Skin Cancer Recurrence
NPR reports a new mRNA vaccine could reduce recurrence and spread of skin cancer, moving mRNA tech from pandemic fame into cutane…
Moderna, Merck Say mRNA Melanoma Vaccine Succeeded in Phase 3
Moderna and Merck say their personalized mRNA cancer vaccine succeeded in a Phase 3 melanoma trial — a first for the mRNA platfor…
Moderna and Merck Report Melanoma Vaccine Success in Large Trial
Moderna and Merck report their personalized mRNA melanoma vaccine succeeded in a large clinical trial, a milestone for mRNA cance…
Moderna-Merck mRNA Vaccine Succeeds in Late-Stage Melanoma Trial
Moderna and Merck said their mRNA cancer vaccine succeeded in a late-stage melanoma trial, per statnews.com, but effect size, end…
Personalised mRNA Vaccine Stops Melanoma Returning in Reported Breakthrough
A personalised mRNA cancer vaccine stopped melanoma from returning, Gavi reports, marking a milestone for individualised neoantig…